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1. Introduction
The right ventricle (RV) has its own particular morphology and functions, which are different
when compared to the left ventricle (LV). In clinical practice, the right heart chambers are often
overlooked, as most physicians tend to focus more on LV and left atrium (LA) morphology
and functions. However, cardiac pathology is often associated with right chambers impair‐
ment, which can occur as a primary pathophysiological response to elevated pressure in the
pulmonary arterial circulation associated with primary pulmonary artery hypertension [1-2],
in pulmonary diseases associated with pulmonary venous or arterial hypertension [3-4],
pulmonary embolism [5], but also in congenital heart disease [6]. Most often, RV dysfunction
is triggered by left chamber impairment [7-9].
Right cardiac imaging is quite challenging, as there are few validated and reproducible
parameters that can be employed for an accurate right atrium (RA) and RV morphology and
function assessment. However, some imaging techniques are available for this purpose.
Nowadays, cardiac magnetic resonance imaging (MRI) is the golden standard for right
chambers evaluation [10], due to its unlimited imaging planes, higher image resolution, and
the ability to calculate volumes using three-dimensional (3D) measurements. Regrettably, this
type of evaluation is not available in many centres and rather expensive, requiring high quality
equipment and highly trained examiners.
Although cardiac MRI is the preferred method [11], echocardiography remains a valuable
alternative, as it is widely available, non-invasive, and less expensive and can be performed
in all patients oblivious of associated pathology or the presence of metallic devices such as
pacemakers, implanted cardioverter defibrillators, cochlear implants or drug infusion pumps.
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Some studies seem to suggest that the risk usually associated with cardiac MRI in patients with
pace makers and defibrillators is overestimated and that examination using magnetic fields
up to 1.5 Tesla can be safe [12-13]. However, performing such an examination is not without
risk and should be attempted in selected patients, with several precautions including complete
resuscitation facilities and in the presence of an electrophysiologist [14]. All in all, cardiac MRI
requires many precautions, in such cases, whereas echocardiography is without risk and easier
to perform. Despite its major advantages, echocardiography has its limitations, mainly due to
the particular morphology of the RV. The thin, trabeculated right free wall and the anterior
position in the chest render RV assessment difficult [15]. Moreover, endocardial border tracing
is strenuous due to the presence of trabeculations, which can be a source of error when
attempting to obtain precise dimension assessment. These downfalls are limited when real-
time 3D echocardiography is used, although, for the time being, end-systolic and end-diastolic
RV volumes seem to be underestimated when compared to cardiac MRI measurements [16].
Some studies have shown, however, that, in spite of the difference in volume measurements,
the correlation between 3D echocardiography and MRI assessment of the right ventricle
ejection fraction (RVEF) is quite strong [17]. All in all, echocardiography can be very useful,
provided that a complex standard protocol is followed.
2. Anatomy and physiology of the right ventricle
The RV has an anterior position in the chest and lies immediately behind the sternum. It has
a triangular or crescent shape and three distinct regions with different embryological origin
and electrophysiological properties. The three regions include: 1) the inlet component, 2) the
apical trabecular component and 3) the outlet component [18]. The inlet component extends
from the tricuspid valve insertion to the level of the papillary muscle, surrounding and
supporting the tricuspid valve and the subvalvular apparatus. The trabecular component
extends from the papillary muscles level to the apex and contains coarse trabeculations. The
inlet and trabecular components have a common embryological origin and form a morpho‐
logical and functional structure called sinus. The sinus is the pivot structure for RV contraction.
The outlet component, also called the infundibulum, conus or the RV outflow tract (RVOT)
has its distinct embryological origin and is functionally different from the sinus. This compo‐
nent has a smooth surface and a minute contribution to RV output volume, and is the last
cardiac structure to be activated, at end systole [19]. This region is particularly important in
patients with congenital heart disease [20] and arrhythmias such as the idiopathic outflow
tachycardia [21], as well as for the diagnosis of arrhythmogenic right ventricle dysplasia
(ARVD), for which the left parasternal long-axis view is usually preferred [22]. All in all, each
region of the RV (Figure 1) is essential in patients with cardiopulmonary disorders and should
be analysed in correlation with segmental coronary vascularisation [18, 23].
RV physiology is closely linked to its anatomical properties. The thin, trabeculated free wall
is adapted to the low pressures in the pulmonary circulation, its dynamics being very different
from that of the LV. RV contraction is generated by the progression of a peristaltic wave which
begins at the inlet and moves towards the infundibulum. RV depolarization triggers the
Hot Topics in Echocardiography12
mechanic activity which consists of inward, longitudinal and circumferential traction; the
systolic function is mainly determined by the longitudinal contraction which causes the
shortening of the ventricle, with equal contribution from the interventricular septum and the
free wall [24]. Several factors contribute to RV global function, namely the preload, afterload
and contractility. The preload is dependant on the volume status, the tricuspid valve gradient
and the venous return from the vena cava. The afterload is determined by the resistance
opposed by the pulmonary valve, the pulsatile flow reflected from the main pulmonary artery,
the impedance of the proximal pulmonary artery and arterioles [25]. Pulmonary vascular
resistance may not, therefore, be used to assess RV total afterload, particularly in patients with
pulmonary hypertension [25]. Due to its thin free wall and high compliance, the RV can easily
adapt to increased preload by dilatation, which can be well tolerated for a long time, although
it eventually leads to RV failure. By contrast, elevated afterload is poorly tolerated from an
early stage, as the RV has little capacity for compensatory hypertrophy, which is quickly
followed by increased stiffness and chamber dilatation [3]. In clinical practice, changes in
preload and afterload alter RV contraction. Other factors that may impair RV systolic function
include abnormal variations of the heart rate, pharmacological agents, or ventricular interde‐
pendence [25]. Ventricular interdependence refers to the fact that the shape, size and compli‐
ance of one ventricle may influence the shape, size or pressures in the other ventricle, an
essential concept for understanding the pathophysiology of RV dysfunction [9].
3. Assessment of right chambers morphology and systolic function
3.1. Echocardiography
Echocardiography can help with qualitative morphological examination by 2D and 3D
echocardiography. Although 2D echocardiography is widely applied in everyday clinical
practice for the morphological and functional assessment of cardiac chambers and valves, 3D
echocardiography is more accurate in assessing chamber volumes, mass and functions and
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Figure 1. Segmental anatomy of right ventricle in correlation with segmental coronary vascularisation. Adapted from
Rudski et al. [23]. RV=right ventricle; RVOT= right ventricular outflow tract; RA=right atrium; RCA=right coronary ar‐
tery; PA=pulmonary artery; LV=left ventricle; LA=left atrium.
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provides a superior view of the valves. 2D echocardiography of the right chambers may
provide diameter, area and volume measurements, which should be indexed to body surface,
and allows the assessment of the systolic pulmonary artery pressure (sPAP) using the tricuspid
regurgitation flow and inferior vena cava (IVC) diameter and its variations during the
respiratory cycle. Newer techniques, such as tissue Doppler and strain-rate imaging, provide
valuable data on the systolic and diastolic functions of the RV.
3.1.1. Right ventricle
A complete evaluation of RV structure should include the study of RV volume, shape and
internal architecture, RV hypertrophy and mass, tissue characterization, assessment for
potential masses [8], and regional wall motion abnormalities [26]. Normally, the RV has a
crescent shape when viewed from the parasternal short-axis incidence; when the RV is
submitted to pressure and volume overload, the crescent shape changes to a D shape, with
subsequent septal flattening, leading to impaired LV filling and decreased output. Septal
movement analysis can help distinguish between RV volume and pressure overload; in the
case of volume overload, septal flattening only occurs during the diastole, whereas, in the
presence of pressure overload, it is persistent throughout the entire cardiac cycle [27-28]. This
phenomenon is quantitatively analyzed by deriving the eccentricity index, calculated as the
RV anteroposterior over the RV septolateral diameter ratio (which may be measured at end-
systole or end-diastole); a value>1 suggests RV overload and was shown to be positively
correlated with pulmonary artery hypertension [29].
a. Acquisition and measurements:
Although qualitative assessment of the RV has its virtues, quantitative assessment provides
more accurate and interpretable data. Morphology assessment may include diameter, area and
volume measurements. RV morphology should be assessed by 2D using several acoustic
windows such as the parasternal long-axis view (which allows RV anterior wall visualisation),
the parasternal short-axis view (to assess the infundibulum and some of the RV anterior wall),
the left parasternal RV inflow window (for the anterior, lateral and inferior RV walls, depend‐
ing on the section level), the subcostal view (for the lateral wall and the infundibulum), the
apical 4-chamber view, and apical 5-chamber view (for assessment of the RV lateral wall) [26]
(Figure 2). Usually, the RV is best measured at end-diastole using the 4-chamber apical view.
From this window, three dimensions can be derived: the basal diameter (the largest diameter
in the basal third of the RV, usually just below the tricuspid annulus); the medial diameter
(measured at the level of the LV papillary muscles); the longitudinal diameter (measured from
the RV apex to the tricuspid annulus plane). RV free wall thickness is best measured from the
subcostal view at the end of the diastole, using either 2D or M-mode imaging techniques;
oblivious of the preferred method, measurements should exclude trabeculations, the papillary
muscle, and the pericardium. RV volume and function may also be assessed by 3D trans‐
thoracic echocardiography using apical and subcostal views. Usually, four-beat images are
necessary to include the entire RV, although newer techniques allow a good evaluation using
a single beat, at the expense of temporal and spatial resolution [26].
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Figure 2. Echocardiography 2D views for right ventricle chamber.
Images are available for off-line analysis, allowing accurate endocardial contours delineation
and RV volumes measurement from sequential long axis planes. End-diastolic measurements
are taken at the peak of the R wave of QRS complexes, while end-systolic volumes are
measured in the first frame before opening of the tricuspid valve [26]. Furthermore, trabecu‐
lations are included in the blood pool. The end-diastolic, end-systolic RV and stroke volume,
as well as RVEF and RV mass are calculated using Simpson’s rule.
b. Qualitative values:
An empirical comparison of LV and RV dimensions allows RV description as (Table 1): normal
(when the RV has smaller dimensions when compared to the LV, with RV apex more basal
than the LV apex); mildly dilated (when the RV is enlarged, but still smaller than the LV);
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moderately dilated (when the RV and LV dimensions are equal); severely dilated (when the
RV is larger than the LV) [30]. However, normal values have been established for quantitative
assessment: a basal diameter >42 mm, a median diameter >35 mm and a longitudinal diameter
>86 mm indicate RV dilatation. The parasternal short-axis view of the great vessels allows
RVOT measurement at the level of the pulmonary valve insertion (the distal diameter) for
which a value of >27 mm signifies RV dilatation. Proximal RVOT diameter can be measured
from either the long or the short-axis parasternal views, with a normal maximum value of 33
mm. However, the former is usually preferred, as it is more reproducible [23]. RV areas are
measured at end-diastole and end-systole, with the following normal values: RV end-diastole
area 20.1 ± 4 cm2 and RV end-systole area 10.9 ± 2.9 cm2 [26, 30]. RV volumes may be calculated
by using either the Simpson method or the area-length method and normal values range
between 63-103 mL for end-diastolic volumes and 22-56 mL for end-systolic volume [31].
However, these 2D echocardiography measurements were proved to be inaccurate by
comparison with 3D echocardiography and cardiac MRI derived volumes. Normal thickness
ranges from 3 to 5 mm [23], and any value surpassing 5 mm suggests RV hypertrophy, which
is usually a response to pressure overload, in the absence of associated pathology, such as
infiltrative or hypertrophic cardiomyopathies [23].
2D echocardiography Referencevalues
Mildly
dilated
Moderately
dilated Severely dilated
RV dimensions
Basal RV diameter (RVD1), mm 20-28 29-33 34-38 "/>39
Mid-RV diameter (RVD2), mm 27-33 34-37 38-41 "/>42
Base-to-apex length (RVL), mm 71-79 80-85 86-91 "/>92
RVOT diameters
Above aortic valve, (RVOT
proximal) mm 25-29 30-32 33-35 "/>36
Above pulmonic valve (RVOT
distal), mm 17-23 24-27 28-31 "/>32
RV area
RV diastolic area, cm2 11-28 29-32 33-37 "/>38
RV systolic area, cm2 7.5-16 17-19 20-22 "/>23
RV volume
RV diastolic volume, mL 63–103
RV systolic volume, mL 22–56
Table 1. Reference limits and partition values of right ventricular size
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The lack of accuracy in assessing RV volumes by 2D echocardiography is mainly determined
by the complex RV geometry and the heavily trabeculated inner wall contour. Real 3D
echocardiography overcomes these limitations and provides a superior evaluation of ventric‐
ular volume, mass and function, as well as a more complete view of the valves [26]. Moreover,
3D echocardiography was proved to be a reliable noninvasive modality of directing the
bioptome to the desired site of biopsy within the RV. In one study, 3D echocardiography
provided accurate anatomic details and was proved to allow sufficient pulmonary valve
visualization in 68% of the patients and an excellent RVOT visualisation in 40% [32]. Normal
medium values of RV end-diastolic and end-systolic volumes were established at 49 ± 10 and
16 ± 6 mL/m2 respectively, with a mean RVEF of 67 ± 8% [33]. Another study provided normal
reference ranges of indexed volumes: 38.6 to 92.2 mL/m2 for RV end-diastolic volume, 7.8 to
50.6 mL/m2 for end-systolic volume, 22.5 to 42.9 mL/m2 for stroke volume in women and higher
values in men: 47.0 to 100 mL/m2 for RV end-diastolic volume, 14.2 to 48.4 mL/m2 for end-
systolic volume, and 23.0 to 52.6 mL/m2 for stroke volume [34].
c. Clinical Application
The structural assessment of the RV provides information concerning the pressure and volume
loading conditions which may lead to functional impairment. The RV gradually adapts to
pressure overload by hypertrophy and interventricular septal flattening, with systolic function
impairment, RV and tricuspid annulus enlargement and aggravated tricuspid regurgitation,
which trigger RV diastolic dysfunction. Therefore, RV morphology should be assessed
periodically in patients with acute or chronic respiratory pathology and valvulopathies with
the purpose of identifying early anomalies which might be corrected by a proper therapeutic
approach. Until recently, the eccentricity index was based on measurements made from the
parasternal short-axis view, at the level of papillary muscles. However, one recent study shows
that these measurements were less accurate than those made at the apical level, which was
superior in terms of correlation with aggravated pulmonary hypertension [35], right chamber
dilatation and RV systolic dysfunction [36]. In addition to that, ultrasound imaging techniques
may identify regional morphologic abnormalities that occur in ARVD, provided the area of
dysplasia is large enough. The diagnosis of ARVD is likely in the presence of significant local
wall aneurysm (major diagnostic criterion), trabeculation disarray, increased thickness of the
moderator band, with hyperechogenic appearance and RVOT dilatation [37]. However,
despite the advantages, the diagnosis of ARVD by imaging techniques cannot rely on echo‐
cardiography alone.
3.1.2. Right atrium
The RA has its own complex pathology, as it responds to both RV volume and pressure
overload. In addition to that, RA enlargement was documented in patients with atrial ar‐
rhythmias such as atrial fibrillation by both 2D and 3D echocardiography; moreover, it has
been proven that RA remodelling occurs in atrial fibrillation and regresses if sinus rhythm is
restored and maintained after radiofrequency catheter ablation [38]. However, RA dilatation
is most often encountered in patients with elevated pulmonary hypertension.
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a. Acquisition and measurements:
The RA is most often visualized from the apical 4-chamber view or the subcostal view [23, 26,
39]. However, due to the fact that standardized data concerning RA assessment is scarce,
current evaluation includes exclusively RA minimum and maximum diameter and RA area
estimation. All these measurements are made by planimetry from the apical 4-chamber view,
at the end of the ventricular systole, when the atrium volume is largest (Figure 3). 3D echo‐
cardiography, although time consuming, may also be employed to calculate RA volume, with
the advantage of more accurate endocardial border tracing at end-systole. To this purpose,
two orthogonal planes (two-plane), four equiangular planes (four-plane), and eight equian‐
gular planes (eight-plane) may be used [40]. All the collected data can be analyzed on and off-
line, with cropping and threshold processing. The final result depends on the accurate and
complementary use of these processing tools [41].
Figure 3. Echocardiography 2D views for right atrium.
b. Qualitative values:
The maximal short-axis distance is measured at mid level, with an upper reference limit of 44
mm. The maximal long axis distance is measured from the center of the tricuspid annular plane
to the center of the RA superior wall, describing a straight line parallel to the interatrial septum;
the threshold for the maximal normal value has been established at 53 mm [23] (Table 2). RA
area provides a more accurate assessment, but it is more time-consuming and, thusly, avoided
by most physicians. The upper reference limit has been established at 18 cm2 or at 9 cm2/m2.
The normal RA volume indexed to body surface area is 34 mL/m2 for men and 27 mL/m2 for
women [26, 36].
2D echocardiography Reference
values
Mildly
dilated
Moderately
dilated
Severely
dilated
RA dimensions
RA minor-axis dimension, mm 29-45 46-49 50-54 "/>55
RA minor-axis dimension/BSA, mm/m2 17-25 26-28 29-31 "/>22
Table 2. Reference limits and partition values for right atrium 2D dimensions
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In 3D echocardiography, RA volumes are calculated using the following formula: 0.85 (D2)/L,
where D is the area in the four-chamber view and L the vertical long-axis [42]. Images should
be taken from three different beats and the loops and tracings from the first examination should
be available during the second and third examination to improve accuracy (Table 3) [42].
RA 3D echocardiography Men Women
RAEF, % 46-74 48-83
RAVI max, mL/m2 18-50 17-41
RAVI min, mL/m2 7-22 5-18
Table 3. Reference limits and partition values for right atrium 3D dimensions
c. Clinical Application
Real-time 3D echocardiography is believed to be a more reproducible and robust method for
atrial volume measurements than 2D echocardiography [42], particularly in the presence of
pathological conditions such as pulmonary disorders, congenital heart disease, valvular
disease, and heart failure.
3.1.3. Inferior vena cava
Right chamber and pulmonary artery pressure assessment also relies on inferior vena cava
(IVC) diameter measurement and the study of its variation during the respiratory cycle. In
normal subjects, the IVC collapses, reducing its diameter with more than 50% after a sniff [43];
during a spontaneous, normal breathing cycle, changes in pleural pressure occur, which
influence RA pressure; while inbreathing, the intrathoracic pressure becomes lower, allowing
a more significant venous return and a decrease in IVC diameter. Respiratory variations are
abolished in case of cardiac tamponade or severe right heart failure [43].
a. Acquisition and measurements:
The subcostal 4-chamber view is used to measure the IVC at end-expiration, proximal to the
emergence of the hepatic veins, which is usually located at 0.5 to 3 cm of the IVC-RA ostium.
Maximum and minimum diameters should be measured perpendicular to the long axis of the
IVC. Measurements may be facilitated by using M-mode (Figure 4).
b. Qualitative values:
Current guidelines [23] established an upper reference limit of 21 mm for IVC diameter. For
an IVC diameter ≤21 mm and an inbreathe variation of >50%, the RA pressure is estimated at
3 mmHg (range 0 – 5 mmHg). If IVC diameter is >21 mm, and the inbreathe collapse is lower
than 50%, the RA pressure is estimated at 15 mmHg (range, 10 – 20 mmHg). However, some
cases do not fit this paradigm; in that situation, if IVC >21 mm and significant collapse (>50%)
occurs after a sniff, or if IVC ≤21 mm, but there is scarcely any inbreathe diameter variation or
none at all, RA pressure is estimated at 8 mmHg (Table 4). Other authors [44] have previously
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suggested a different approach (Table 4). The reference normal value interval for the IVC
diameter was set at 15 – 25 mm; if the measured IVC diameter remained within these limits,
and decreased with >50% after a sniff, the RA pressure was estimated at 5 – 10 mmHg; if
inbreathe variation was <50%, RA pressure was estimated at 10 – 15 mmHg, and at 15 – 20
mmHg if IVC diameter was greater than 25 mm. If IVC was dilated and remained flat during
the respiratory cycle, and dilated hepatic veins were also visualized, RA pressure was
considered to be >20 mmHg.
Figure 4. Measurement and view of the inferior vena cava (IVC) perpendicular to the long axis at end-expiration, just
proximal to the junction of the hepatic veins that lie proximal to the ostium of the right atrium.
IVC diameter Change after “sniff” Estimated right atrium pressure (mmHg)
Estimated right atrium pressure by Rudski [23]
≤ 21 mm Collapse "/>50% 3 mmHg (range 0 – 5 mmHg)
"/> 21 mm Collapse <50% 15 mmHg (range 10 – 20 mmHg)
"/>21 mm Collapse "/>50% 8 mmHg (range 5 – 10 mmHg)
≤ 21 mm Collapse <50% 8 mmHg (range 5 – 10 mmHg)
Estimated right atrium pressure by Otto [43]
Normal range (15–25 mm) Collapse "/>50% 5 – 10 mmHg
Normal range (15–25 mm) Collapse <50% 10 – 15 mmHg
Dilated ("/>25 mm) Collapse <50% 15 – 20 mmHg
Dilated ("/>25 mm) Flat "/> 20 mmHg
Table 4. Right atrium pressure assessment by inferior vena cava collapse and inbreathe variation
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c. Clinical Application
Oblivious of the approach, estimated RA pressure is added to the tricuspid regurgitation
gradient in order to calculate the systolic pulmonary artery pressure (sPAP). Usually, IVC
diameter is only used to assess sPAP, and is not interpreted individually. However, one study
focused on idiopathic pulmonary hypertension patients showed that an IVC diameter ≥20 mm,
with respiratory variation <50%, was a prognostic factor for mortality [45]. In some cases, such
as young athletes, dehydrated patients or in the presence of mechanical respiratory assistance
devices, IVC diameter correlates poorly with RA pressure.
3.1.4. Right ventricle systolic function
Assessing RV systolic function can be difficult, due to the particular morphology of the RV.
Geometrical assumptions are based on pyramidal and ellipsoidal models which are not
particularly accurate, as the RV has a rather irregular shape. Moreover, area and volume
estimation can be impaired by the presence of trabeculations in the RV, which should be
excluded from myocardial border tracings. For volume calculation, area-length and disk
summation (Simpson’s) methods are used, the latter being more accurate. However, volumes
are underestimated by 2D echocardiography [46], when compared to 3D echocardiography
[47] and cardiac MRI [34]. Cardiac computed tomography may also be used, but RV volumes
tend to be overestimated using this imaging technique [48], while cardiac MRI remains the
gold standard for RV assessment, although it was shown to correlate very well with real-time
3D echocardiography measurements [11]. These imaging techniques are often unavailable in
most centres, rendering 2D echocardiography quite important, despite its downfalls. A
complete 2D echocardiography examination should include area and volume assessment, as
well as several derived parameters (Table 5), such as right ventricle fractional area change
(RVFAC) and the RVEF, tricuspid annular plane systolic excursion (TAPSE), systolic velocity
of the myocardium (St wave) and right ventricular myocardial performance index (RVMPI).
2D echocardiography Reference values Mildlydilated
Moderately
dilated
Severely
dilated
RVFAC, % 32-60 25-31 18-24 <17
RVEF, % 43–65 40-30 30-20 <20
TAPSE, mm 15-20 13-15 10-12 <10
Table 5. Reference limits and partition values of right ventricular systolic function as measured in the apical 4-
chamber view
a. Right ventricle fractional area change
The RVFAC is estimated using the formula: (end-diastolic area – end-systolic area)/end-
diastolic area x 100, with a lower reference value for normal RV systolic function of 35% [23]
and was previously proved to diminish in primary pulmonary hypertension patients, when
compared to healthy controls [49] (Figure 5). Normal RVFAC and partition values [30] are
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shown in Table 5. In one study, RVFAC was found to be an independent predictor of heart
failure, stroke and higher mortality in patients with prior myocardial infarction [50].
Figure 5. Measurement of the right ventricular fractional area change (RVFAC), views for right ventricle chamber.
b. Right ventricular ejection fraction
The RVEF is derived using the formula: (end-diastolic volume – end-systolic volume)/end-
diastolic volume, for which the minimal normal value was established at 44% (Figure 6).
Although RVEF measurement by echocardiography is impaired by geometrical assumptions,
difficult endocardial border tracing and the fact that the RVOT is not included in area and
volume assessment, it is still a valuable parameter, as some studies showed that RVEF is a
strong and independent predictor of mortality in heart failure [51-52]. Both RVFAC and RVEF
were proved to significantly correlate with other RV function parameters such as the myocar‐
dial performance index [53]. As mentioned above, the RV systolic function is dependent on
the LV function and can be altered in the presence of interventricular septum movement
abnormalities. The LV systolic function is mostly determined by the radial contraction, while
the thin RV free wall systolic movement is predominantly determined by longitudinal
shortening.
c. Tricuspid annular plane systolic excursion
To assess RV free wall systolic shortening, the TAPSE is measured. This parameter is assessed
using the apex-4-chamber view and the M-mode; the cursor is placed at the level of the
tricuspid annular plane, allowing the examiner to assess the base to apex motion of the annular
plane during systole (Figure 7). The minimal reference threshold has been established at 16
mm (normal values ranging around 22 ± 4 mm) and it is inferred that higher TAPSE values
correspond to a better systolic function. TAPSE is easy to measure, reproducible, does not
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require special equipment and is valuable when assessing RV function after myocardial
infarction, but does present with some downfalls, particularly due to the fact that it only reflects
the basal segment function, ignoring other regions. Moreover, it is angle and load dependant.
However, some studies have shown that it correlates well with RVFAC and Simpson’s method
derived RVEF [35, 54], as well as ventriculography derived RVEF [24] and that it is highly
reliable as a prognostic tool in pulmonary hypertension [52, 55], heart failure [24] and dilated
cardiomyopathy, oblivious of the ischemic or non-ischemic aetiology [52].
Some level of correspondence has been demonstrated between TAPSE (in mm) and RVEF; a
TAPSE of 5 mm corresponds to a 20% RVEF, 10 mm to a 30% RVEF, 15 mm to 40%, 20 mm to
50% [56].
d. Tissue Doppler analysis
Tissue Doppler imaging’s (TDI) may be used to obtain other indices of RV performance such
as the St wave, the isovolumic contraction velocity and the derived myocardial acceleration
(Figure 8) during isovolumic contraction. All these parameters are quite independent of
anatomical properties and do not rely on any geometrical assumptions, but may be influenced
by load conditions. As they are angle dependent, Doppler beam alignment should be optimal.
The isovolumic contraction velocity is measured using either pulsed or colour-coded TDI with
sample volume placement on the RV free wall at the level of the tricuspid annulus. The
isovolumic contraction phase starts immediately after the A’ wave corresponding to ventric‐
ular filling during atrial systole and precedes the St wave which describes ventricle wall
movement during the ejection phase. In one study, the isovolumic contraction velocity was
shown to correlate very well with mean RA pressure and proved to have 100% sensitivity and
78% specificity for a cut-off value <6 cm/s [57-58].
Figure 6. Measurement of the right ventricular ejection fraction (RVEF), views for right ventricle chamber.
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Figure 8. Pulsed wave tissue Doppler with the sample placed at the level of the tricuspid annulus of the RV free wall,
demonstrating peak systolic velocity (St), and myocardial acceleration during isovolumic contraction (IVA).
This parameter may further be used to derive the myocardial acceleration during isovolumic
contraction (IVA) which is calculated as the peak isovolumic contraction velocity divided by
the time to peak velocity. Myocardial acceleration during isovolumic contraction may be
measured either by pulsed-wave TDI or colour-coded TDI, but normal values seem to be
different; in one study, values proved to be up to 20% higher when assessed by pulsed-wave
TDI, by comparison with colour-coded TDI evaluation [23] [59]. In addition to that, normal
values vary with age [60] and heart rate. For tissue Doppler assessment, pooled data from 10
studies established a lower reference value of 2.2 m/s [23]. IVA was studied on several animal
models which lead to significant conclusions which may be implemented in every day practice.
Figure 7. Measurement of the tricuspid annular plane systolic excursion (TAPSE) in normal and pulmonary artery hy‐
pertension individual, in the four chamber view a straight line (M mode) is drawn through the lateral tricuspid valve
annulus.
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Vogel et al. conducted a study on pigs, proving that IVA is afterload and preload independent
[61], while Hashimoto et al. conducted their research on sheep, proving that IVA correlates
very well with peak positive dp/dt measured invasively by right heart catheterization [62]. In
humans, studies have shown that IVA was significantly correlated with disease severity in
patients with chronic obstructive pulmonary disease [63], obstructive sleep apnoea [64], RV
remodelling triggered by type 2 diabetes mellitus [65], and that it may be used for early
detection of RV dysfunction in patients with mitral stenosis [66] or systemic sclerosis, even
before the onset of pulmonary hypertension [67]. Moreover, in one study on patients who
underwent corrective surgery for transposition of the great arteries, IVA was proved to be
superior to the peak systolic myocardial velocity in assessing the reduction of functional
reserve, in both the RV and LV [68].
TDI may also be used for measuring the highest St wave. This parameter is obtained from the
apical four chamber view by positioning the sample volume either at the level of the tricuspid
annulus, on the lateral wall, or in the middle or apical segments segment. The latter locations
are, however, avoided by most physicians as adequate signals are rarely obtained and
measurements are less reproducible, with greater interobserver variability [58]. St may be
measured using pulsed tissue or colour coded TDI, and is, as other TDI parameters, angle
dependent, but less influenced by loading conditions or RV anatomy when compared to other
systolic function parameters. Mean annular velocities have been established at 8.5 – 10 cm/s,
while basal free wall velocities are slightly higher at 9.3 – 11 cm/s [23], with lower velocities in
elderly subjects due to the increased stiffness of the myocardium [60, 69, 70]. The main
limitation of this parameter is determined by the fact that it only reflects changes in systolic
movement of the basal segment which are extrapolated as descriptive for the systolic function
of the entire RV. This type of measurement may sometimes be inaccurate in the presence of
segmental RV systolic dysfunction which may occur in some clinical conditions such as RV
myocardial infarction, ARVD or pulmonary embolism. A St value under 10 cm/s should rise
suspicion of RV dysfunction, especially in young subjects, although a minimum reference
value was established at 6 cm/s by pooled data from several studies [23]. In one research, a St
value of <12 cm/s showed high sensitivity (81%), specificity (82%) and negative predictive
value (92%) for the diagnosis of RV myocardial infarction [71], while Meluzin et al. demon‐
strated it was significantly correlated with RVEF and that a value <11.5 cm/s predicted RV
systolic dysfunction with 90% sensitivity and 85% specificity in patients with heart failure [72].
Also, St was also shown to be lower, as expected, in patients with systemic sclerosis [67].
e. Right ventricular myocardial performance index
Both the systolic and diastolic functions of the RV may be evaluated using the myocardial
performance index, also known as RVMPI or Tei index. This index can be obtained either by
pulsed Doppler or TDI and is defined by the ratio of isovolumic time/ejection time. The ejection
time is assessed by placing the pulsed Doppler cursor at the level of the RVOT and is measured
from the onset to the cessation of the systolic pulmonary artery flow. When the pulsed Doppler
cursor is placed at the level of the tricuspid annulus, the time from the cessation of the A wave
to the onset of the next E wave is measured and the difference between this interval and the
ejection time signifies the total isovolumic time (isovolumic resting time + isovolumic con‐
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traction time). These measurements are taken from two different acoustic windows and,
implicitly, in different points in time, therefore errors can occur if the RR interval is not regular.
Consequently, measurements may only be made if the rhythm is regular and are not feasible
in case of atrial fibrillation. When using the TDI method, measurements are taken during a
single heart beat, by placing the cursor at the level of the tricuspid annulus (Figure 9). The
isovolumic contraction time (IVCT) is measured from the cessation of the At wave to the
beginning of the St wave, the ejection time (ET) – from the onset to the cessation of the St wave,
and the isovolumic relaxation time (IVRT) – from the end of the S’ wave to the onset of the Et
wave. The correlation between the tissue Doppler and pulsed Doppler methods are modest,
due to differences in isovolumic times, which lead to higher cut-off points when tissue Doppler
is used, as it was shown in studies focused on the LV [73, 74]. Moreover, one recent study
showed that LV Tei index assessment by tissue Doppler was better correlated with the LV
ejection fraction in patients with heart failure [75]. Similar results were obtained in a study on
a paediatric population with congenital heart disease which showed that the TDI derived Tei
index values were different from those obtained by pulsed Doppler and that they had
additional utility, as they might help differentiate systolic from diastolic dysfunction by
providing specific information on the isovolumetric intervals [76]. For the RVMPI, the upper
reference limit has been established at 0.40 by the pulsed Doppler method and at 0.55 by the
tissue Doppler method [23]. Any values above these thresholds are considered to be patho‐
logical, as stated by Brierre et al. who obtained a mean value of the Tei index of 0.90 in their
research on idiopathic pulmonary artery hypertension patients; moreover, they showed that
values ≥0.98 were associated with increased mortality [45].
Up to date, RVMPI was proved to be useful for RV function assessment in several studies.
One study on patients with acute RV myocardial infarction showed that the Tei index was
valuable  for  diagnosis,  RV function quantification and,  interestingly,  for  acute  improve‐
ment assessment [77].
In another research by Blanchard et al. conducted on patients with chronic thromboembolic
pulmonary hypertension, RVMPI was shown to be a valuable tool for monitoring disease
severity and for assessing outcome after pulmonary thrombo-endarterectomy, and positively
correlated with pulmonary vascular resistance, measured by right heart catheterization [78].
Moreover, RVMPI was shown to be a high sensitivity and specificity parameter for diagnostic
purposes in patients with acute pulmonary embolism, as well as a valuable tool for assessing
the response to efficient anticoagulant therapy [79-81]. In addition to that, Haddad et al.
demonstrated that both the RVMPI and the RVFAC may have an incremental prognostic value
in terms of mortality and morbidity after valvular heart surgery [82], while others confirmed
its utility in assessing global RV function in children with congenital heart disease [83-84]. The
Tei index also proved its value in RV function assessment in patients with sleep apnoea, as it
was positively correlated with the anoxia-hypoxia index, while RVFAC showed inverse
correlation with the same parameter [85].
The echocardiographic evaluation of RV by RVMPI has many advantages, as it is non-invasive,
widely available, reproducible and independent of any geometric assumptions. If the pulsed
wave Doppler method is used, errors may occur if the RR interval is variable. This downfall
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may, however, be limited by using the tissue Doppler method which allows measurement
taking during a single heart beat, but results are still unreliable in patients with atrial fibrilla‐
tion. Other disadvantages include load dependency and altered results when RA pressure is
elevated, due to artificial IVRT shortening which leads to lower RVMPI values [86].
Figure 9. Measurement of right ventricular myocardial performance index (RVMPI) by pulsed wave Doppler of tricus‐
pid regurgitation and tissue Doppler with the sample placed at the level of the tricuspid annulus of the RV free wall.
f. Analyzing the tricuspid regurgitation flow
RV systolic function assessment can also be performed by analyzing the tricuspid regurgitation
flow, which is commonly visualized from the apical 4-chamber view. Using continuous-wave
Doppler, several parameters can be derived, such as: RV-RA pressure gradient, systolic,
diastolic and mean pulmonary artery pressure (sPAP; dPAP; mPAP), the rate of pressure rise
in the RV (dp/dt), and the previously described right index of myocardial performance
(RVMPI). To this purpose, an optimal parallel alignment of the continuous Doppler cursor to
the tricuspid regurgitation (TR) flow should be obtained. The rate of pressure rise in the RV
(dp/dt) was first described in 1962 and measured invasively by right heart catheterization. An
echocardiographic method based on the Bernoulli equation was developed to serve the same
purpose, although it was shown that continuous-wave Doppler analysis of the TR flow
significantly underestimated peak RV pressures when compared to invasive measurements
[87]. The rate of pressure rise is calculated by measuring the time interval in which the tricuspid
flow velocity rises from 1 m/s to 2 m/s (Figure 10). Based on the Bernoulli equation, this rise
in velocity corresponds to a pressure elevation of 12 mmHg. Other researchers suggest that
dp/dt assessment correlates better with invasive measurements if the studied time interval is
focused on a rise in velocity from 0.5 to 2 m/s, which corresponds to a 15 mmHg rise in pressure
[88]. The value of dp/dt is expressed in mmHg/sec, but normal reference values have not been
established so far; this parameter, although easy to obtain, has limited clinical value, also due
to the fact that it is load and angle dependent. However, values <400 mmHg/s are likely to be
abnormal [23]. One small study showed that the dp/dt over maximum RV pressure ratio had
a significant correlation to the NYHA functional class, while dp/dt by itself had none at all [89].
Nowadays, this parameter is of little interest.
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Figure 10. Measurement of the rate of pressure rise in the ventricles (dp/dt) of tricuspid regurgitation in the four
chamber view in pulmonary artery hypertension individual.
The RV-RA pressure gradient may also be estimated using the peak velocity of the TR flow
based on the simplified Bernoulli equation: peak pressure gradient of TR= 4 x (TR maximum
velocity)2. As it is angle dependant, the best possible alignment of the continuous-wave
Doppler cursor with the regurgitation jet should be obtained and several measurements, from
several acoustic windows (most often, apical 4 chamber view and parasternal RV inflow view),
should be taken (Figure 11). The signal with the highest velocity and density should be used;
the Doppler signal may be enhanced by injecting agitated saline into the venous flow.
Moreover, special attention is necessary to exclude RVOT obstruction, which often occurs in
congenital heart disease. sPAP is then calculated by adding the estimated RA pressure
(assessed by IVC diameter and its inbreathe variations, as described above) to the RV-RA
gradient.
Figure 11. Doppler echocardiographic determination of systolic pulmonary artery pressure (sPAP).
A tricuspid regurgitation jet maximum velocity of ≤ 2.8 m/s renders pulmonary hypertension
unlikely, a velocity of >3.4 m/s – likely, while values between 2.8 m/s and 3.4 m/s indicate that
pulmonary hypertension is possible [90-91]. Normal resting values have been established at
≤36 mmHg for peak systolic pressure, assuming a RA pressure of 3-5 mmHg [23, 92].
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The severity of pulmonary hypertension may be underestimated in the presence of severe
tricuspid regurgitation that leads to elevated RA pressure and, consequently, to a lesser RV-
RA pressure gradient and lower sPAP (Table 6).
TR maximum velocity PAPs Other echo parameterssuggesting HTP*
PH unlikely ≤ 2.8 m/s ≤ 36 mmHg
PH possible ≤ 2.8 m/s ≤ 36 mmHg +
2.9 – 3.4 m/s 37 – 50 mmHg +/-
PH likely >3.4 m/s >50 mmHg
* dilated right chambers; increased thickness of the RV free wall; abnormal shape and function of the interventricular
septum; dilated pulmonary artery; increased velocity of the pulmonary regurgitation jet; short acceleration time of RV
ejection in the pulmonary artery; PH - pulmonary hypertension
Table 6. Arbitrary criteria for the presence of pulmonary hypertension based on continuous Doppler derived systolic
pulmonary artery pressure (sPAP) and tricuspid regurgitation (TR) jet maximum velocity [90].
Like the sPAP, the dPAP can be derived by applying the Bernoulli equation to the pulmonary
regurgitation flow: dPAP=4 x (end-diastolic regurgitant velocity)2 + RA pressure. The pulmona‐
ry regurgitation flow may also be used to calculate the mPAP pressure after the same princi‐
ple, by the formula mPAP= (4 x early PR velocity) + RA pressure, or by adding RA pressure to
the velocity time integral (VTI) of the tricuspid regurgitation, the latter method being the most
accurate, as it correlates better to invasive measurements by right heart catheterization [93, 94].
Previous methods relied on more vague estimations, based on the sPAP and dPAP: mPAP= 1/3
sPAP + 2/3 dPAP, or obtained by analysing the pulmonary artery continuous wave Doppler
flow, using the formula mPAP= 79 – (0.45 x AT) (AT= acceleration time) [95].
The AT is measured from the onset of the pulmonary flow, which corresponds to the onset of
the QRS complex on the ECG, to the onset of the maximum pulmonary velocity; consequently,
the shorter the AT, the higher the mPAP. This formula applies when the heart rate is between
60 and 100 bpm, and the AT is below 120 msec. A study showed, however, that, in case of
aggravated pulmonary hypertension, when AT shortens below this threshold, the formula
mPAP= 90 – (0.62 x AT) led to more accurate results [95]. Despite the technical progress and
reasonable mathematical and physical assumptions, right chamber and pulmonary pressure
assessment by echocardiography is not sufficient for diagnosing pulmonary hypertension. In
pulmonary artery hypertensive patients, right heart catheterisation remains the golden
standard [94], as it is needed to confirm the diagnosis, to assess severity and to test for vessel
reactivity if specific therapy is considered [90]. Several studies have shown that sPAP is
considerably underestimated by echocardiography when compared to right heart catheteri‐
zation, oblivious of the used method [96-98]. However, despite all the limitations, the assess‐
ment of pulmonary artery pressures by echocardiography can be used as a screening method
for pulmonary hypertension [90, 94].
g. Regional RV Strain and Strain Rate
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Strain and strain rate (SR) imaging can provide valuable data on the relative deformation of
myocardial segments under stress. The resting length of the myocardium (L0) changes when
submitted to a certain force (L1). Myocardial strain is best described by the L1-L0/L0 ratio,
expressed in a certain percentage, which is negative when shortening occurs and positive when
the myocardium lengthens. The SR can be derived using strain and the velocity of myocardial
deformation, expressed in 1/s. The particular anatomy of the RV, which is mainly composed of
longitudinal and oblique fibres, renders it highly susceptible to strain variations at lower stress
when compared to the LV [99]. Right myocardial velocities are, thusly, higher than in the LV and
more elevated at the apex, when compared to the base, even in normal individuals [99].
TDI-derived and speckle-tracking echocardiography-derived strain and SR can be used to
assess RV dynamics and were found to be both feasible and roughly comparable. Strain and
SR correlate well with radionuclide RVEF [24].
Normal strain is 19 ± 6 % in the basal RV free wall, 27 ± 6 %, in the median and 32 ± 6 % at the
apex for the prediction of RVEF >50% [100]. This renders strain assessment of the RV quite
strenuous, with important limitations due to the need of perfect alignment of the TDI cursor
to the rather thin free wall of the RV. In addition to that, strain analysis is highly dependent
on hemodynamic variations [101]. In patients with RV disease or dysfunction, peak systolic
strain and SR are significantly reduced and delayed compared with individuals with normal
RV function [24].
RV speckle-tracking is less challenging in terms of angle issues, provided that optimal
endocardial border tracking is performed [102]. In 2D speckle-tracking analysis, a certain
selected zone is studied in motion, allowing a good assessment of the longitudinal, radial and
torsion movements of the RV (Figure 12); however, this method is limited by a low temporal
resolution [102].
h. 3D echocardiography
3D echocardiography may also be used to assess right ventricle systolic and diastolic functions.
It has been previously demonstrated that 3D echocardiography-derived RVEF correlated
 
Figure 12. Measurement of global right ventricular deformation by speckle-tracking with the sample placed at the
level of the RV free wall in normal and pulmonary artery hypertension individual.
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negatively with 2D-derived pulmonary arterial systolic pressure and positively with TAPSE,
the peak systolic velocity, and the fractional shortening area [32]. In one study, patients with
mitral valve prolapse who underwent surgical treatment had significantly lower TAPSE and
peak systolic velocities of the tricuspid annulus after surgery, while 3D-derived RVEF
remained the same (58.4 ± 4%) [32]. Moreover, 3D echocardiography analysis was used to
describe RV systolic function in patients with various cardiovascular disorders, showing that
patients with pulmonary hypertension had the largest RV volumes and RVEF, while those
with idiopathic dilated cardiomyopathy had considerably lower RVEF when compared to
patients with valvular heart disease [32].
In another study, normal RVEF reference values were established at 38.0% to 65.3% for women
and 29.9% to 58.4% for men [34].
3.2. Cardiac magnetic resonance imaging
Nowadays, cardiac MRI is considered to be the gold standard for determining RV volume and
function [11]. This method should be taken into account when 3D echocardiography is not
sufficient for evaluation.
a. Acquisition and measurements:
Cardiac MRI requires a minimum 1.5 Tesla scanner, with a phased-array cardiac coil. Cine
imaging acquired 2-chamber and 4-chamber views allow the positing of a retrospectively ECG-
gated steady-state free procession pulse sequence using following parameters: repetition time
3.5–4.2 ms, echo time 1.5–1.8 ms, flip-angle 45°, matrix 256 × 256, field of view 250–350 mm,
slice thickness 5–8 mm with a gap of 0–2 mm depending on body size; 12 slices should be
acquired [10]. Cardiac MRI allows an accurate delineation of the endocardial and epicardial
borders in all planes and all cardiac phases; in addition to that, the systolic descent and twist
of the tricuspid valve is quantified by tracking of the valve motion on the long-axis cines in
order to correct for loss of systolic RV volume due to AV ring descent; thirdly, papillary
muscles are delineated, with blood pool thresholding. This technique allows the calculus of
RV end-systolic and end-diastolic volumes, RV ejection fraction and right ventricular mass
with a great degree of precision [103-104]. Cardiac MRI allows a complete assessment of the
RV inflow and outflow, regardless of ventricular size or shape. The extent of myocardial
damage or fibrosis is evaluated using late gadolinium enhancement.
b. Qualitative values:
Several reference values for RV volumes have been mentioned, with significant gender
differences; consequently, larger RV volumes were documented in males when compared to
females: RV end-diastolic volume 190 ± 33 mL vs. 148 ± 35 mL, RV end-systolic volume 78 ±
20 mL vs. 56 ± 18 mL [105]. Other values were obtained in another study, which compared
MRI-derived volumes against 3D echocardiography volumes, proving the former were larger.
The following mean normal values were established for RV end-diastolic, end-systolic, and
stroke volumes: 134.2 ± 39.2 mL vs. 124.0 ± 34.4 mL; 69.7 ± 25.5 mL vs. 65.2 ± 23.5 mL; and 64.5
± 24.1 mL vs. 58.8 ± 18.4 mL [106].
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c. Clinical Application
The efficiency of 3D echocardiography vs. cardiac MRI in RV assessment was compared in
many studies. One research group conducted a study on 60 pulmonary artery hypertensive
patients [4], proving that 3D echocardiography had some advantages over cardiac MRI, as it
could be routinely used for serial imaging and at the bedside. Moreover, it was previously
shown that both 3D echocardiography and cardiac MRI may be used to assess RV remodeling
in pulmonary artery hypertension patients [11, 34, 107]. However, cardiac MRI results proved
to be more reproducible in terms of assessing RV ejection fraction and RV mass [26]. Although
less available, cardiovascular MRI is frequently used nowadays to describe RV systolic
function; recent imaging techniques allow a good assessment of parameters such as ventricular
volumes, ejection fraction, and myocardial mass, with increased accuracy when compared to
echocardiography. Stroke volumes, cardiac output, and volumes routed through cardiac
shunts can be derived using flow velocities and cross sectional areas. These methods are similar
to those used in Doppler echocardiography, but provide a better accuracy, as MRI velocity
analysis can be conducted in any orientation or plane. Tissue parameters are best visualized
by contrast enhancement techniques (contrast-enhanced MRI), which typically use gadolini‐
um-based magnetic contrast agents [103]. Similar to strain echocardiography, tagged MRI is
used to study the 3-dimensional motion and deformation in the heart. Tags are regions of the
myocardium, whose longitudinal magnetization has been altered before imaging which
render them dark in MRI. These dark areas are landmarks within the heart which allow the
detection of motion. In one study on patients with idiopathic pulmonary arterial hypertension,
tagged MRI was used to identify significant interventricular asynchrony caused by a pro‐
longed RV systolic contraction time, probably due to impaired electrical conductivity in the
right ventricle. It was then showed that ventricular asynchrony led to impaired LV diastolic
filling and, consequently, to decreased LV end-diastolic volumes [108]. Although further
research would be needed to validate reproducible parameters for RV evaluation, echocar‐
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Figure 13. Cardiac MRI steady-state free procession sequence for the assessment of right ventricular function en-dia‐
stolic and en-systolic. RV=right ventricle; LV=left ventricle.
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diography and cardiac MRI based techniques are, for the time being, of immense value. As
mentioned before, cardiovascular MRI is nowadays considered to be the gold standard for RV
assessment; in one research, some 3D echocardiography-derived measurements, such as the
RVEF, compared well against cardiac MRI results, with little difference (47.8 ± 8.5% vs 48.2 ±
10.8%) [106]. However, in another study, a tendency to overestimate RVEF by 3D echocar‐
diography, with a bias of approximately 13% (95% CI -52% to +27%), has been reported;
moreover, in the same research, RV diastolic and RV systolic volumes were shown to be
systematically and significantly underestimated by 3D echocardiography [109]. Solid correla‐
tions were established between 2D echocardiography tissue Doppler St wave velocity and
MRI-derived RVEF [110]. In addition to that, it was shown that a systolic long-axis peak
velocity of <11 cm/s at the lateral tricuspid annulus was associated with moderately impaired
MRI-derived RVEF, while severely reduced RVEF ≤30% was best detected by RVMPI at a value
of >0.50 [111].
4. Assessment of right ventricular diastolic dysfunction
4.1. Echocardiography
4.1.1. Tissue Doppler analysis
a. Acquisition and measurements:
The assessment of RV diastolic dysfunction strongly resembles LV evaluation. Validated
parameters include the tricuspid flow E and A velocities, as well as the E/A ratio, the E wave
deceleration time and the IVRT, which are assessed in a similar manner to mitral flow
evaluation; the previously mentioned parameters are measured using the apical 4-chamber
view by placing sample volume at the tips of the tricuspid leaflets.
Several limitations undermine the accuracy of tricuspid flow parameters, particularly the
preload and afterload dependency. Preload variations are significant during the respiratory
cycle due to fluctuant intrathoracic pressure, which is diminished during inbreathing and rises
during expiration. Low intrathoracic pressure favours venous return to the RA, leading to
better atrial filling and increased pressure; as a consequence, early diastolic ventricular filling
is improved, with an increase in E wave velocity, while A wave velocities remain almost the
same; subsequently, the E/A ratio may change. Conversely, lower E wave velocities are
obtained when preload decreases during expiration. This is why some authors suggest that at
least 5 beats should be analysed in each patient in order to obtain an average value that should
have clinical significance [112]. Other physiological factors that influence tricuspid flow
patterns are age, gender and tachycardia [112]. Measurements may also be altered by the
presence of severe tricuspid regurgitation or atrial fibrillation [23]. Moreover, the thin-walled
RV is also highly sensitive to afterload variations, particularly in patients with myocardial
infarction or chronic ischemia [113]. TDI is another valuable tool for assessing RV diastolic
function. TDI is used to measure velocities at the level of the tricuspid annulus (Et, At, Et/At)
and to derive the E/Et ratio which is gaining interest as a marker of diastolic dysfunction. In
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clinical practice, both pulsed and colour TDI may be used; the former technique is simpler and
provides a high temporal resolution, but is hindered by low spatial resolution [114]; the latter
has high spatial resolution, but lower temporal resolution and provides mean velocities [115],
as opposed to pulsed TDI, by which maximum velocities are measured. Although considered
superior to pulsed wave Doppler techniques, TDI measurements have their limitations. Firstly,
like pulsed Doppler parameters, they are influenced by age and gender [116].
Figure 14. Pulsed wave tissue Doppler with the sample placed at the level of the tricuspid annulus of the RV free wall,
demonstrating diastolic parameters (Et and At).
b. Qualitative values:
Moreover, although previous studies focused on the LV supported TDI load independency
[117], Pelà et al. demonstrated in their research on healthy subjects that RV Et and At wave
velocities were dependent on loading conditions; however, they also showed that Et and At
velocity variations were proportional, and consequently, despite alterations in preload, the Et/
At ratio remained constant. [118]. According to Horton et al., measuring parameters from ≥ 3
different beats during apnoea may reduce errors derived from load variations and the
translational motion of the myocardium [119]. Despite the limitations, several researches have
confirmed that pulsed and tissue Doppler allow a clinically significant evaluation of RV
diastolic function. Puwanat et al. demonstrated that a tricuspid E/Et ratio >6 was associated
with a mean right atrium pressure >10 mmHg in patients with heart failure and preserved
ejection fraction [120]; this finding was consistent with data from a previous research by
Utsunomyia et al. who demonstrated that intraatrial pressure assessment by use of the E/Et
ratio was comparable with invasive hemodynamic measurements obtained by right heart
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catheterization and valuable as a prognostic tool for cardiovascular events in patients with
chronic pulmonary artery hypertension [121] (Table 7).
Degree of diastolic dysfunction Tricuspid E/A ratio Additional parameters
Impaired relaxation < 0.8 E/Et >6
Pseudonormal filling 0.8 – 2.1 diastolic flow predominance in the hepaticveins TDE < 120 msec
Restrictive filling > 2.1 late systolic anterograde flow in thepulmonary artery
Table 7. Right ventricle diastolic dysfunction assessment
c. Clinical Application
As in the case of the left ventricle, RV diastolic function is the first to be impaired, preceding
systolic dysfunction. Therefore, when RV impairment is suspected, diastolic function assess‐
ment is advised, as RV diastolic dysfunction has been confirmed as a marker of poor prognosis
[23]. Most studies support the use of the following parameters: trans-tricuspid E/A ratio,
E/Et ratio, and RA size [23].
4.1.2. Color M-mode flow propagation velocity
a. Acquisition and measurements:
Color M-Mode flow propagation velocity (Vp) is most commonly measured by the slope
method from the apical 4-chamber view, using color flow imaging with a narrow color sector;
gain is adjusted to avoid noise. The M-mode cursor is placed at the center of the RV inflow
blood column from the tricuspid valve to the apex. The color flow baseline is shifted to lower
the Nyquist limit so that the central highest velocity jet is blue. Flow propagation velocity (Vp)
is measured as the slope of the first aliasing velocity during early filling, measured from the
tricuspid valve plane to 4 cm distally into the RV cavity. Alternatively, the slope of the
transition from no color to color may be measured.
b. Qualitative values:
Vp values >50 cm/s are considered normal for the RV. The Et/Vp ratio varies proportionally with
RA pressure, and may therefore be used either by itself, or in combination with IVRT to assess
filling pressures.  However, this rather challenging method is redundant in patients with
decreased RV ejection fraction in which other parameters precisely identify diastolic dysfunction.
c. Clinical Application
The slowing of tricuspid-to-apical flow propagation measured by color M-mode Doppler is
valuable in identifying diastolic dysfunction. In addition, it may help in assessing filling
pressures when used in conjunction with tricuspid E. Essays were made to measure non-
invasively the tricuspid-to-apical pressure gradient by color M-mode Doppler, but the method
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is not currently intended for routine clinical application, due to its difficulty. The non-invasive
imaging assessment of the RV has gained raising interest and recent research has provided
data which may improve standard clinical protocols. However, highly accurate reference
values are yet to be established, and there are currently few available and reproducible
parameters.
Figure 15. Pulsed color M-mode Vp imaging with the sample placed at the level of the tricuspid annulus of the RV
free wall in pulmonary artery hypertension individual.
4.2. Cardiac magnetic resonance imaging
a. Acquisition and measurements:
The assessment of RV diastolic dysfunction by cardiac MRI is similar, as a principle, to the
echocardiographic evaluation. 1.5 Tesla systems can be used to characterize the transtricuspid
flow. To this purpose, 4-chamber views should be acquired. ECG-gated phase-contrast pulse
sequences are positioned retrospectively, in a plane perpendicular to the transtricuspid inflow,
at the level of the opened tricuspid tips, just bellow the tricuspid valve annulus. Two dynamic
phase-contrast series, corresponding to an entire cardiac cycle, are acquired during breathhold:
1) the transtricuspid flow velocity sequence, and 2) a myocardial longitudinal velocity
sequence. Due to technical progress, cardiac MRI is increasingly being used for blood and
myocardial velocities assessment. In addition to that, several studies have demonstrated the
usefulness of phase-contrast MRI for measuring diastolic function parameters [122]. However,
these analyses are mostly based on manual positioning of regions of interest (ROIs) within the
transtricuspid flow area or the myocardium on multiple phases [122, 123]. The derivative of
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the time/volume curve, expressed as peak filling rate is used to quantify diastolic function. The
early and active peak tricuspid filling rates (PFRE and PFRA) and their ratio may be calculated
[104].
b. Qualitative values:
Maceira et al [104] published the first normal ranges for MRI-derived RV diastolic function:
PFRE=371 mL/s, or 202 mL/m2, PFRA=429 mL/s, or 233 mL/m2, PFRE/PFRE = 0.9 were signifi‐
cantly higher in males [104].
5. Hemodynamic assessment
As previously mentioned, Doppler echocardiography may be used for the non-invasive,
indirect assessment of pulmonary artery pressures. To this purpose, the RV-RA pressure
gradient is calculated by analyzing the tricuspid regurgitation flow and the obtained value is
added to the estimated RA pressure; the latter is estimated by measuring the IVC and its
collapsibility after a “sniff”. The value of sPAP thusly derived is somewhat empirical. Several
studies have shown that Doppler echocardiography systematically under- or overestimates
pulmonary pressures, by comparison with direct, invasive measurements by right heart
catheterization [96, 124].
Currently, right heart catheterization remains the gold standard for pulmonary artery pressure
assessment, as it is necessary to confirm the diagnosis, assess hypertension severity and the
reactivity to vasodilator agents [90]. Invasive measurements are particularly useful in patients
with NYHA II and III heart failure who have mild pulmonary hypertension as assessed by
echocardiography. In addition to that, right heart catheterization provides the advantage of
vasoreactivity testing, which is compulsory before initiating vasodilator therapy and may help
predict the response to treatment; nitric oxide, adenosine and epoprostenol are most com‐
monly used for this purpose [90]. Patients who have an acute response to vasoreactivity testing
are more likely to respond to long-tem therapy [125].
In conclusion, echocardiography may be used as a screening method, as it indicates the
likelihood of pulmonary artery hypertension, rather than providing an actual diagnosis.
Results should always be validated by right heart catheterization, particularly if specific
vasodilator treatment is intended. All in all, 2D echocardiography has some limitations, some
related to the empirical assessment of sPAP, others to the imprecision in chamber measure‐
ments due to geometrical assumptions or difficult endocardial border tracing. Presently,
cardiac MRI is the golden standard in RV structure and function evaluation, due to its
unlimited imaging planes, higher image resolution, and the ability to calculate volumes using
three-dimensional measurements; however, cardiac MRI is seldom available in many centres,
and hindered by prolonged acquisition and processing times. Moreover, its use is still limited
in patients with implanted metallic devices, such as pace-makers, defibrillators, metallic
prostheses or insulin pumps. Right heart catheterization allows a good evaluation of sPAP,
but it is an invasive procedure and is not usually performed in the absence of other evidence
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of pulmonary artery hypertension. Standard 2D echocardiography is widely available,
relatively cheap, does not present any risk for the patient, and may be performed even in the
presence of metallic devices which would normally hinder an MRI examination. Although it
only indicates the likelihood of pulmonary artery hypertension, it may be used to select
candidates for right catheterization. In terms of assessing RV structure and function, further
research would be needed in order to provide solid, reproducible parameters, with normal
reference values.
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